Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 11, 2021
Reporting Period: The filing announces financial results for the year ended December 31, 2020.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. Consequently, this filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. It only confirms the issuance of a press release detailing the 2020 results.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on March 11, 2021, announcing its financial results for the year ended December 31, 2020.
Legal Status of Information: The information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 11, 2021) for specific revenue, net income, and cash flow figures for the year ended December 31, 2020.
- Verify the Company's liquidity position and debt obligations as detailed in the referenced press release.
- Confirm any forward-looking statements or guidance provided in the press release, as they are not included in this 8-K text.